• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?寡转移非小细胞肺癌：我们应如何定义和管理它？
J Oncol Pract. 2018 Jan;14(1):32-34. doi: 10.1200/JOP.2017.028290.
2
Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer.评论：使手术在寡转移非小细胞肺癌中具有相关性
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1629-1630. doi: 10.1016/j.jtcvs.2018.10.124. Epub 2018 Nov 8.
3
Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.立体定向消融放疗（SABR）用于肺部寡转移/寡复发非小细胞肺癌患者：一种新的治疗方法。
Anticancer Res. 2015 Nov;35(11):6239-45.
4
Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer.寡转移非小细胞肺癌患者管理中的局部治疗指征
Surg Oncol Clin N Am. 2016 Jul;25(3):611-20. doi: 10.1016/j.soc.2016.02.007.
5
Risk factors and management of oligometastatic non-small cell lung cancer.寡转移非小细胞肺癌的危险因素与管理
Ther Adv Respir Dis. 2016 Aug;10(4):338-48. doi: 10.1177/1753465816642636. Epub 2016 Apr 8.
6
[Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].[立体定向体部放射治疗寡转移非小细胞肺癌（NSCLC）：一例报告]
Cancer Radiother. 2015 May;19(3):192-7. doi: 10.1016/j.canrad.2014.12.007. Epub 2015 Apr 1.
7
[Treatment of oligometastatic or oligoprogression cancer].[寡转移或寡进展性癌症的治疗]
Cancer Radiother. 2019 Oct;23(6-7):482-485. doi: 10.1016/j.canrad.2019.07.143. Epub 2019 Sep 5.
8
The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.立体定向消融放疗（SBRT）在寡转移非小细胞肺癌治疗中的作用。
Lung Cancer. 2016 Feb;92:22-8. doi: 10.1016/j.lungcan.2015.11.015. Epub 2015 Dec 2.
9
Treatment options for brain metastases in patients with non-small-cell lung cancer.非小细胞肺癌患者脑转移的治疗选择
Curr Oncol Rep. 2003 Jul;5(4):342-6. doi: 10.1007/s11912-003-0077-8.
10
Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.寡转移非小细胞肺癌的消融治疗。
Clin Lung Cancer. 2017 Nov;18(6):595-606. doi: 10.1016/j.cllc.2017.03.002. Epub 2017 Mar 14.

引用本文的文献

1
Survival outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical therapy: a multicenter analysis.寡转移非小细胞肺癌患者接受根治性治疗的生存结果：一项多中心分析。
Turk J Med Sci. 2023 Aug;53(4):949-961. doi: 10.55730/1300-0144.5659. Epub 2023 Aug 18.
2
Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study.非小细胞肺癌根治性治疗后异时性寡转移患者微观转移的预测：一项微观模拟研究
Cancers (Basel). 2021 Apr 14;13(8):1884. doi: 10.3390/cancers13081884.
3
Surgery for stage IV non-small cell lung cancer?IV期非小细胞肺癌的手术治疗？
J Thorac Dis. 2020 Apr;12(4):1612-1614. doi: 10.21037/jtd.2020.03.32.

本文引用的文献

1
Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer.寡转移非小细胞肺癌患者的管理。
J Oncol Pract. 2018 Jan;14(1):23-31. doi: 10.1200/JOP.2017.026500.
2
Baseline tumour measurements predict survival in advanced non-small cell lung cancer.基线肿瘤测量可预测晚期非小细胞肺癌的生存。
Br J Cancer. 2013 Sep 17;109(6):1476-81. doi: 10.1038/bjc.2013.472. Epub 2013 Aug 13.
3
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.局部消融治疗寡进展性疾病可延长致癌基因依赖性非小细胞肺癌患者对酪氨酸激酶抑制剂的疾病控制时间。
J Thorac Oncol. 2012 Dec;7(12):1807-1814. doi: 10.1097/JTO.0b013e3182745948.
4
"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.“脉冲式”高剂量每周厄洛替尼治疗 EGFR 突变型非小细胞肺癌脑转移。
Neuro Oncol. 2011 Dec;13(12):1364-9. doi: 10.1093/neuonc/nor121. Epub 2011 Aug 24.
5
Preoperative staging of lung cancer with combined PET-CT.采用PET-CT联合检查对肺癌进行术前分期
N Engl J Med. 2009 Jul 2;361(1):32-9. doi: 10.1056/NEJMoa0900043.
6
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.转移性肺癌一线全身治疗后巩固性立体定向体部放射治疗是否有作用？失败模式分析。
Acta Oncol. 2009;48(4):578-83. doi: 10.1080/02841860802662722.
7
Parallel progression of primary tumours and metastases.原发性肿瘤和转移灶的平行进展。
Nat Rev Cancer. 2009 Apr;9(4):302-12. doi: 10.1038/nrc2627.
8
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.非小细胞肺癌孤立性同步与异时性肾上腺转移瘤肾上腺切除术的结果：一项系统评价和汇总分析
J Clin Oncol. 2008 Mar 1;26(7):1142-7. doi: 10.1200/JCO.2007.14.2091.
9
Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.非小细胞肺癌伴发同步性孤立性脑转移
Cancer. 2006 May 1;106(9):1998-2004. doi: 10.1002/cncr.21818.
10
Tumor size, sensitivity to therapy, and design of treatment schedules.肿瘤大小、对治疗的敏感性以及治疗方案的设计。
Cancer Treat Rep. 1977 Oct;61(7):1307-17.

Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It?

作者信息

Gerber David E

机构信息

Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

出版信息

J Oncol Pract. 2018 Jan;14(1):32-34. doi: 10.1200/JOP.2017.028290.

DOI:10.1200/JOP.2017.028290
PMID:29324207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5765903/
Abstract
摘要